NASDAQ:LQDA Liquidia (LQDA) Stock Forecast, Price & News $8.89 +0.26 (+3.01%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$8.61▼$8.9050-Day Range$6.63▼$8.8952-Week Range$3.38▼$8.90Volume276,807 shsAverage Volume470,616 shsMarket Capitalization$575.36 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Liquidia MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside57.5% Upside$14.00 Price TargetShort InterestHealthy3.04% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.66Based on 3 Articles This WeekInsider TradingSelling Shares$5,260 Sold Last QuarterProj. Earnings GrowthDecreasingFrom ($0.71) to ($0.74) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.95 out of 5 starsMedical Sector583rd out of 983 stocksPharmaceutical Preparations Industry289th out of 486 stocks 3.3 Analyst's Opinion Consensus RatingLiquidia has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $14.00, Liquidia has a forecasted upside of 57.5% from its current price of $8.89.Amount of Analyst CoverageLiquidia has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.04% of the outstanding shares of Liquidia have been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in Liquidia has recently decreased by 8.37%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldLiquidia does not currently pay a dividend.Dividend GrowthLiquidia does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LQDA. Previous Next 1.3 News and Social Media Coverage News SentimentLiquidia has a news sentiment score of -0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Liquidia this week, compared to 3 articles on an average week.Search Interest4 people have searched for LQDA on MarketBeat in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Liquidia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,260.00 in company stock.Percentage Held by Insiders29.20% of the stock of Liquidia is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.64% of the stock of Liquidia is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Liquidia are expected to decrease in the coming year, from ($0.71) to ($0.74) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Liquidia is -15.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liquidia is -15.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLiquidia has a P/B Ratio of 7.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Liquidia (NASDAQ:LQDA) StockLiquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The company was founded on June 28, 2020 and is headquartered in Morrisville, NC.Read More Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter. Email Address LQDA Stock News HeadlinesMay 31, 2023 | finance.yahoo.comLiquidia Corporation to Present at the 2023 Jefferies Healthcare ConferenceMay 30, 2023 | finance.yahoo.comInvesting in Liquidia (NASDAQ:LQDA) a year ago would have delivered you a 106% gainJune 4, 2023 | Behind the Markets (Ad)WARNING: Do You Invest with these BanksTake a close look at the investment banks above. Because if you have stocks with any of these brokerages... These new political developments WILL affect you.May 19, 2023 | finance.yahoo.comLiquidia Announces Poster Presentation at the 2023 American Thoracic Society International ConferenceMay 17, 2023 | americanbankingnews.comLiquidia Co. (NASDAQ:LQDA) Short Interest Down 7.3% in AprilMay 13, 2023 | americanbankingnews.comQ2 2023 EPS Estimates for Liquidia Co. Reduced by Wedbush (NASDAQ:LQDA)May 10, 2023 | msn.comHC Wainwright & Co. Reiterates Liquidia (LQDA) Buy RecommendationMay 10, 2023 | markets.businessinsider.comWedbush Sticks to Its Sell Rating for Liquidia Technologies (LQDA)June 4, 2023 | Chaikin Analytics (Ad)Famous Wall Street Crash System Flashes REDHundreds of banks, hedge funds, and brokerages have paid $5,000 a month to access these alerts. Because when this system flashes on U.S. stocks, huge gains – and losses – can follow.May 10, 2023 | msn.comWedbush Reiterates Liquidia (LQDA) Underperform RecommendationMay 10, 2023 | americanbankingnews.comLiquidia Co. Expected to Earn Q2 2023 Earnings of ($0.16) Per Share (NASDAQ:LQDA)May 9, 2023 | finance.yahoo.comInstitutional investors are Liquidia Corporation's (NASDAQ:LQDA) biggest bettors and were rewarded after last week's US$60m market cap gainMay 4, 2023 | finance.yahoo.comLiquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 2, 2023 | finance.yahoo.comLiquidia Corporation to Present at BofA Securities 2023 Health Care ConferenceApril 27, 2023 | finance.yahoo.comLiquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023April 23, 2023 | americanbankingnews.comNeedham & Company LLC Reaffirms "Buy" Rating for Liquidia (NASDAQ:LQDA)April 19, 2023 | msn.comNeedham Reiterates Liquidia (LQDA) Buy RecommendationApril 18, 2023 | finance.yahoo.comLiquidia Corporation's (NASDAQ:LQDA) Earnings Haven't Escaped The Attention Of InvestorsApril 11, 2023 | finance.yahoo.comLiquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare ConferenceApril 3, 2023 | finance.yahoo.comLiquidia and GSK Restructure License to PRINT Technology for Inhaled ApplicationsMarch 30, 2023 | americanbankingnews.comFinancial Comparison: Liquidia (NASDAQ:LQDA) & Quoin Pharmaceuticals (NASDAQ:QNRX)March 25, 2023 | finance.yahoo.comIndustry Analysts Just Made A Captivating Upgrade To Their Liquidia Corporation (NASDAQ:LQDA) Revenue ForecastsMarch 24, 2023 | americanbankingnews.comLiquidia Co. Forecasted to Post Q1 2023 Earnings of ($0.21) Per Share (NASDAQ:LQDA)March 22, 2023 | americanbankingnews.comWedbush Comments on Liquidia Co.'s Q1 2023 Earnings (NASDAQ:LQDA)March 21, 2023 | americanbankingnews.comEquities Analysts Offer Predictions for Liquidia Co.'s Q2 2023 Earnings (NASDAQ:LQDA)March 21, 2023 | americanbankingnews.comLiquidia (NASDAQ:LQDA) Price Target Raised to $18.00 at Needham & Company LLCMarch 20, 2023 | markets.businessinsider.comWedbush Remains a Sell on Liquidia Technologies (LQDA)See More Headlines LQDA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LQDA Company Calendar Last Earnings3/16/2023Today6/03/2023Next Earnings (Estimated)8/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LQDA CUSIPN/A CIK1819576 Webwww.liquidia.com Phone(919) 328-4400FaxN/AEmployees52Year FoundedN/APrice Target and Rating Average Stock Price Forecast$14.00 High Stock Price Forecast$20.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+57.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,010,000.00 Net Margins-217.39% Pretax Margin-217.39% Return on Equity-39.89% Return on Assets-27.80% Debt Debt-to-Equity RatioN/A Current Ratio14.62 Quick Ratio14.62 Sales & Book Value Annual Sales$15.94 million Price / Sales36.10 Cash FlowN/A Price / Cash FlowN/A Book Value$1.26 per share Price / Book7.06Miscellaneous Outstanding Shares64,720,000Free Float45,820,000Market Cap$575.36 million OptionableNot Optionable Beta0.09 Key ExecutivesRoger A. JeffsChief Executive Officer & DirectorRobert A. LippeChief Operating OfficerMichael KasetaChief Financial OfficerRajeev SaggarChief Medical OfficerScott MoomawChief Commercial OfficerKey CompetitorsPhathom PharmaceuticalsNASDAQ:PHATCalliditas Therapeutics AB (publ)NASDAQ:CALTBicycle TherapeuticsNASDAQ:BCYCEvolusNASDAQ:EOLSZymeworksNYSE:ZYMEView All CompetitorsInsiders & InstitutionsPrelude Capital Management LLCBought 23,384 shares on 6/1/2023Ownership: 0.072%Scott MoomawSold 651 sharesTotal: $5,260.08 ($8.08/share)SkyView Investment Advisors LLCBought 90,200 shares on 5/18/2023Ownership: 0.139%JPMorgan Chase & Co.Bought 9,431 shares on 5/18/2023Ownership: 0.058%New York State Common Retirement FundSold 14,100 shares on 5/18/2023Ownership: 0.030%View All Insider TransactionsView All Institutional Transactions LQDA Stock - Frequently Asked Questions Should I buy or sell Liquidia stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Liquidia in the last twelve months. There are currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LQDA shares. View LQDA analyst ratings or view top-rated stocks. What is Liquidia's stock price forecast for 2023? 4 brokerages have issued twelve-month price targets for Liquidia's shares. Their LQDA share price forecasts range from $3.00 to $20.00. On average, they predict the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 57.5% from the stock's current price. View analysts price targets for LQDA or view top-rated stocks among Wall Street analysts. How have LQDA shares performed in 2023? Liquidia's stock was trading at $6.37 at the beginning of 2023. Since then, LQDA stock has increased by 39.6% and is now trading at $8.89. View the best growth stocks for 2023 here. When is Liquidia's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023. View our LQDA earnings forecast. How were Liquidia's earnings last quarter? Liquidia Co. (NASDAQ:LQDA) released its earnings results on Thursday, March, 16th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.17) by $0.08. The firm earned $5.36 million during the quarter, compared to the consensus estimate of $3.65 million. Liquidia had a negative net margin of 217.39% and a negative trailing twelve-month return on equity of 39.89%. What ETFs hold Liquidia's stock? ETFs with the largest weight of Liquidia (NASDAQ:LQDA) stock in their portfolio include SPDR S&P Kensho New Economies Composite ETF (KOMP), Invesco Nasdaq Future Gen 200 ETF (QQQS), Principal Healthcare Innovators ETF (BTEC), What other stocks do shareholders of Liquidia own? Based on aggregate information from My MarketBeat watchlists, some companies that other Liquidia investors own include VBI Vaccines (VBIV), OPKO Health (OPK), Aldeyra Therapeutics (ALDX), Sorrento Therapeutics (SRNE), vTv Therapeutics (VTVT), Genocea Biosciences (GNCA), Inovio Pharmaceuticals (INO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA) and NVIDIA (NVDA). When did Liquidia IPO? (LQDA) raised $50 million in an initial public offering (IPO) on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers. What is Liquidia's stock symbol? Liquidia trades on the NASDAQ under the ticker symbol "LQDA." Who are Liquidia's major shareholders? Liquidia's stock is owned by many different institutional and retail investors. Top institutional shareholders include Caligan Partners LP (14.28%), BlackRock Inc. (5.00%), State Street Corp (4.11%), Geode Capital Management LLC (1.44%), Two Sigma Advisers LP (0.89%) and Mitsubishi UFJ Kokusai Asset Management Co. Ltd. (0.86%). Insiders that own company stock include Arthur S Kirsch, Caligan Partners Lp, Eshelman Ventures, Llc, Michael Kaseta, Paul B Manning, Robert A Lippe, Roger Jeffs, Russell Schundler and Scott Moomaw. View institutional ownership trends. How do I buy shares of Liquidia? Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Liquidia's stock price today? One share of LQDA stock can currently be purchased for approximately $8.89. How much money does Liquidia make? Liquidia (NASDAQ:LQDA) has a market capitalization of $575.36 million and generates $15.94 million in revenue each year. The company earns $-41,010,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis. How can I contact Liquidia? Liquidia's mailing address is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. The official website for the company is www.liquidia.com. The company can be reached via phone at (919) 328-4400 or via email at ir@liquidia.com. This page (NASDAQ:LQDA) was last updated on 6/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.